Debra Weih
- Cancer Research top 10%
- NF-κB Signaling Pathways 7
- Immunology top 10%
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 3
- Immune Response and Inflammation 2
- Immune Cell Function and Interaction 2
- Galectins and Cancer Biology 1
-
- Cytokine Signaling Pathways and Interactions 2
-
- Cholesterol and Lipid Metabolism 1
- Co-authors
- Falk WeihZ. Buket YilmazElke MeierFeng GuoA LovasKarl BauerHeike HeuerMarija Trajkovic‐Arsic
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Debra Weih
13 papers receiving 556 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 231
- Immunology 301
- Oncology 138
- Endocrinology, Diabetes and Metabolism 70
- Molecular Biology 182
Countries citing papers authored by Debra Weih
This map shows the geographic impact of Debra Weih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Weih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Weih more than expected).
Fields of papers citing papers by Debra Weih
This network shows the impact of papers produced by Debra Weih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Weih. The network helps show where Debra Weih may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Debra Weih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 54 | |
| 2 | 2015 | 19 | |
| 3 | 2013 | 9 | |
| 4 | 2012 | 21 | |
| 5 | 2012 | 32 | |
| 6 | 2012 | 21 | |
| 7 | 2010 | 69 | |
| 8 | 2009 | 62 | |
| 9 | 2008 | 20 | |
| 10 | 2007 | 13 | |
| 11 | 2007 | 44 | |
| 12 | 2001 | 179 | |
| 13 | 2001 | 18 |
About Debra Weih
Debra Weih is a scholar working on Cancer Research, Immunology, Oncology, Endocrinology, Diabetes and Metabolism and Hematology, having authored 13 papers that have together received 561 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (7 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (3 papers), Immune Response and Inflammation (2 papers), Immune Cell Function and Interaction (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Galectins and Cancer Biology (1 paper) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Cancer Research (231 citations), Immunology (301 citations), Oncology (138 citations), Endocrinology, Diabetes and Metabolism (70 citations) and Molecular Biology (182 citations). Debra Weih has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Falk Weih, Z. Buket Yilmaz, Elke Meier, Feng Guo, A Lovas, Karl Bauer, Heike Heuer, Marija Trajkovic‐Arsic, Theo J. Visser and Marc Riemann. Their work appears in journals such as PLoS ONE, European Journal of Immunology, Blood, The Journal of Immunology and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.